Immunohistochemical Correlation of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Tobacco Associated Epithelial Dysplasia

被引:11
|
作者
Bajracharya, Dipshikha [1 ]
Shrestha, Bijayatha [1 ]
Kamath, Asha [2 ]
Menon, Aparna [3 ]
Radhakrishnan, Raghu [3 ]
机构
[1] Manipal Univ, Manipal Educ & Med Grp, Manipal 576104, Karnataka, India
[2] Manipal Univ, Kasturba Med Coll, Manipal 576104, Karnataka, India
[3] Manipal Univ, Manipal Coll Dent Sci, Dept Oral & Maxillofacial Pathol, Manipal 576104, Karnataka, India
关键词
SQUAMOUS-CELL CARCINOMA; UP-REGULATION; MMP-9; EXPRESSION; CANCER; ACTIVATION; INVASION; MATRIX-METALLOPROTEINASE-2; PROGRESSION; MODEL; GENE;
D O I
10.1155/2014/197813
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim. To study the immunohistochemical expression of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinase-2 in different histological grades of tobacco associated epithelial dysplasia and correlate the association between these proteases. Potentially malignant oral disorders (PMODs) progressing to oral cancer are related to the severity of epithelial dysplasia. Methods. A retrospective immunohistochemical study was carried out on 30 clinically and histologically proven cases of leukoplakia with dysplasia and 10 cases of normal buccalmucosa using anti-MMP-2 and anti-TIMP-2 monoclonal antibodies. Results. Mann Whitney U test, for comparing the expression of both MMP-2 and TIMP-2 in normal mucosa with dysplasia, was highly significant (P < 0.001). Kruskal-Wallis test to compare the median score of MMP-2 and TIMP-2 in different grades of dysplasia showed statistical significance (P < 0.001), and a Spearman's correlation between MMP-2 and TIMP-2 through different grades of dysplasia and cells observed showed positive correlation. Conclusion. Concomitant increase in the expression of both MMP-2 and TIMP-2 suggested that the activation of MMP-2 is dependent on TIMP-2 acting as a cofactor. Changes in TIMP-2 levels are considered important because they directly affect the level of MMP-2 activity.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [2] Correlation between serum matrix metalloproteinase-2/tissue inhibitors of metalloproteinase-2 ratio and elevated pulmonary vascular resistance
    Hisazaki, K.
    Uzui, H.
    Arakawa, K.
    Amaya, N.
    Kaseno, K.
    Ishida, K.
    Morishita, T.
    Sato, T.
    Lee, J. D.
    Tada, H.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 36 - 36
  • [3] Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas
    Coven, Ilker
    Ozer, Ozge
    Ozen, Ozlem
    Sahin, Feride Iffet
    Altinors, Nur
    [J]. JOURNAL OF NEUROSURGERY, 2014, 121 (06) : 1478 - 1482
  • [4] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231
  • [5] Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma
    Xu, KX
    Hou, SK
    Du, ZJ
    [J]. CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 743 - 745
  • [6] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
    Li, Bing-Hui
    Zhao, Peng
    Liu, Shi-Zheng
    Yu, Yue-Ming
    Han, Mei
    Wen, Jin-Kun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) : 3046 - 3050
  • [7] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 gene polymorphisms in multiple sclerosis
    Benesova, Y.
    Beranek, M.
    Hladikova, M.
    Vacha, J.
    Kadanka, Z.
    Vasku, A.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 68 - 68
  • [8] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [9] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    [J]. South China Journal of Cardiology, 2010, 11 (01) : 15 - 19
  • [10] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    [J]. ORAL ONCOLOGY, 2011, 47 : S84 - S84